4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-18-019635
Options or other derivatives
- Chief Medical Officer acquired 260,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Culwell Kelly Chief Medical Officer | 2018-03-12 | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | D | ||
Loading xslF345X03/doc4.xml…